These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 18373426

  • 1. Gadofullerene MRI contrast agents.
    Bolskar RD.
    Nanomedicine (Lond); 2008 Apr; 3(2):201-13. PubMed ID: 18373426
    [Abstract] [Full Text] [Related]

  • 2. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents.
    Tóth E, Bolskar RD, Borel A, González G, Helm L, Merbach AE, Sitharaman B, Wilson LJ.
    J Am Chem Soc; 2005 Jan 19; 127(2):799-805. PubMed ID: 15643906
    [Abstract] [Full Text] [Related]

  • 3. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P, Dellinger A, MacFarland D, Stern S, Dobrovolskaia M, Ileva L, Patri AK, Bernardo M, Brooks DB, Zhou Z, McNeil S, Kepley C.
    Invest Radiol; 2013 Nov 19; 48(11):745-54. PubMed ID: 23748228
    [Abstract] [Full Text] [Related]

  • 4. Nanotechnology and MRI contrast enhancement.
    Matson ML, Wilson LJ.
    Future Med Chem; 2010 Mar 19; 2(3):491-502. PubMed ID: 21426177
    [Abstract] [Full Text] [Related]

  • 5. Gadolinium-containing endohedral fullerenes: structures and function as magnetic resonance imaging (MRI) agents.
    Ghiassi KB, Olmstead MM, Balch AL.
    Dalton Trans; 2014 May 28; 43(20):7346-58. PubMed ID: 24522668
    [Abstract] [Full Text] [Related]

  • 6. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P.
    Acc Chem Res; 2009 Jul 21; 42(7):851-62. PubMed ID: 19222207
    [Abstract] [Full Text] [Related]

  • 7. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E, Negri V, Soler-Padrós J, Cerdán S, Ballesteros P.
    Eur J Radiol; 2008 Sep 21; 67(3):453-8. PubMed ID: 18455343
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Application of fullerenes in nanomedicine: an update.
    Dellinger A, Zhou Z, Connor J, Madhankumar AB, Pamujula S, Sayes CM, Kepley CL.
    Nanomedicine (Lond); 2013 Jul 21; 8(7):1191-208. PubMed ID: 23837857
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Destroying gadofullerene aggregates by salt addition in aqueous solution of Gd@C(60)(OH)(x) and Gd@C(60)[C(COOH(2))](10).
    Laus S, Sitharaman B, Tóth E, Bolskar RD, Helm L, Asokan S, Wong MS, Wilson LJ, Merbach AE.
    J Am Chem Soc; 2005 Jul 06; 127(26):9368-9. PubMed ID: 15984854
    [Abstract] [Full Text] [Related]

  • 12. Facile preparation of a new gadofullerene-based magnetic resonance imaging contrast agent with high 1H relaxivity.
    Shu C, Corwin FD, Zhang J, Chen Z, Reid JE, Sun M, Xu W, Sim JH, Wang C, Fatouros PP, Esker AR, Gibson HW, Dorn HC.
    Bioconjug Chem; 2009 Jun 06; 20(6):1186-93. PubMed ID: 19445504
    [Abstract] [Full Text] [Related]

  • 13. MRI contrast agents: basic chemistry and safety.
    Hao D, Ai T, Goerner F, Hu X, Runge VM, Tweedle M.
    J Magn Reson Imaging; 2012 Nov 06; 36(5):1060-71. PubMed ID: 23090917
    [Abstract] [Full Text] [Related]

  • 14. Gd3N@C84(OH)x: a new egg-shaped metallofullerene magnetic resonance imaging contrast agent.
    Zhang J, Ye Y, Chen Y, Pregot C, Li T, Balasubramaniam S, Hobart DB, Zhang Y, Wi S, Davis RM, Madsen LA, Morris JR, LaConte SM, Yee GT, Dorn HC.
    J Am Chem Soc; 2014 Feb 12; 136(6):2630-6. PubMed ID: 24432974
    [Abstract] [Full Text] [Related]

  • 15. Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents.
    Mikawa M, Kato H, Okumura M, Narazaki M, Kanazawa Y, Miwa N, Shinohara H.
    Bioconjug Chem; 2001 Feb 12; 12(4):510-4. PubMed ID: 11459454
    [Abstract] [Full Text] [Related]

  • 16. Gadolinium contrast agent selection and optimal use for body MR imaging.
    Guglielmo FF, Mitchell DG, Gupta S.
    Radiol Clin North Am; 2014 Jul 12; 52(4):637-56. PubMed ID: 24889165
    [Abstract] [Full Text] [Related]

  • 17. Metallofullerenes: a new class of MRI agents and more?
    Fatouros PP, Shultz MD.
    Nanomedicine (Lond); 2013 Nov 12; 8(11):1853-64. PubMed ID: 24156489
    [Abstract] [Full Text] [Related]

  • 18. Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.
    Cheng W, Ping Y, Zhang Y, Chuang KH, Liu Y.
    J Healthc Eng; 2013 Nov 12; 4(1):23-45. PubMed ID: 23502248
    [Abstract] [Full Text] [Related]

  • 19. High-relaxivity MRI contrast agents prepared from miniemulsion polymerization using gadolinium(III)-based metallosurfactants.
    Gong P, Chen Z, Chen Y, Wang W, Wang X, Hu A.
    Chem Commun (Camb); 2011 Apr 14; 47(14):4240-2. PubMed ID: 21359276
    [Abstract] [Full Text] [Related]

  • 20. Aggregation studies of the water-soluble gadofullerene magnetic resonance imaging contrast agent: [Gd@C82O6(OH)16(NHCH2CH2COOH)8]x.
    Shu CY, Zhang EY, Xiang JF, Zhu CF, Wang CR, Pei XL, Han HB.
    J Phys Chem B; 2006 Aug 10; 110(31):15597-601. PubMed ID: 16884284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.